Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2017-04-10 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
东北证券股份有限公司关于公司重大资产购买之标的资产2016年度业绩承诺实现情况的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an independent financial advisor's opinion on the performance commitment realization of a major asset purchase for the year 2016. It references a special audit report by an accounting firm and provides verification of the target asset's net profit achievement against promised figures. The document is a verification or audit opinion related to a specific transaction's performance commitment, not a full annual report or interim financial report. It is a standalone audit-related opinion on a specific matter, fitting the category of Audit Report / Information (AR). The document length is 1767 characters, which is short but contains substantive audit verification content, not merely an announcement or certification. Therefore, it is classified as AR with high confidence. FY 2016
2017-04-10 Chinese
2017年第一季度业绩预告修正公告
Earnings Release Classification · 95% confidence The document is a performance forecast revision announcement for the first quarter of 2017 by Changchun Dirui Medical Technology Co., Ltd. It provides estimated net profit figures for the period January 1 to March 31, 2017, revising previous guidance upwards. The document explicitly states that the financial data has not been audited and that detailed financial data will be disclosed in the company's 2017 first quarter report. The document is short (958 characters) and serves as an announcement of revised earnings guidance rather than a full financial report. It does not contain actual financial statements or substantive financial data, only preliminary estimates. Therefore, it is best classified as an Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. Q1 2017
2017-04-07 Chinese
2016年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It includes detailed financial statements such as consolidated balance sheets, profit and loss statements, cash flow statements, and changes in shareholders' equity for the fiscal year ending December 31, 2016. The document also contains the auditor's opinion, responsibilities of management and auditors, and signatures of responsible persons. The length is substantial (15,000 characters), and it contains the full audit report and financial statements, not just an announcement or certification. Therefore, this document fits the category of a standalone Audit Report / Information filing. FY 2016
2017-03-24 Chinese
国信证券股份有限公司关于公司2016年度募集资金存放与使用专项核查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "募集资金存放与使用专项核查报告" which translates to a "Special Inspection Report on the Deposit and Use of Raised Funds" for the year 2016. It is issued by the sponsor (国信证券股份有限公司) for 长春迪瑞医疗科技有限公司. The content details the management, storage, and usage of funds raised from the company's IPO in 2014, including bank accounts, usage progress, and audit opinions from an accounting firm. The document is a specialized audit or verification report focusing on the use of raised capital, not a full annual report or earnings release. It includes audit opinions and verification of compliance with regulatory requirements related to raised funds. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report on a specific aspect of the company's financials (fundraising and usage), not the full annual report or interim report. The document length (4827 characters) is sufficient to contain substantive content, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-03-24 Chinese
关于公司控股股东及其他关联方资金占用情况汇总表的专项审核报告
Audit Report / Information Classification · 95% confidence The document is a special audit report on the summary table of funds occupied by controlling shareholders and other related parties of Changchun Dirui Medical Technology Co., Ltd. It references a specific audit report number (瑞华核字 [2017]22020003 号) and is focused on the audit of related party fund occupation for the fiscal year ending December 31, 2016. The document includes an auditor's opinion and detailed tables related to the audit findings. It is not a full annual report, nor is it a general regulatory filing or announcement. It is a standalone audit report specifically addressing a particular audit subject, consistent with the definition of an Audit Report / Information (AR). The document length is 2296 characters, which is short but contains substantive audit content, not merely an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-03-24 Chinese
2016年度独立董事述职报告（康熙雄）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2016 from Changchun Dirui Medical Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions on company matters, committee work, investor protection efforts, learning activities, and other work during the year. The content focuses on governance, oversight, and the independent director's role rather than financial results or audit opinions. It is not a full annual report (10-K), audit report (AR), or earnings release (ER). It is a detailed report on board/management activities and governance related to the independent director's duties. Therefore, the best fitting category is Board/Management Information (MANG). The document length (2561 characters) and content confirm it is a substantive report, not a brief announcement or certification, so it is not RNS or RPA.
2017-03-24 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.